119 related articles for article (PubMed ID: 10464014)
1. Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as platelet aggregation inhibitors. 2. Optimization by quantitative structure-activity relationships.
Campillo N; Goya P; Páez JA
J Med Chem; 1999 Aug; 42(17):3279-88. PubMed ID: 10464014
[TBL] [Abstract][Full Text] [Related]
2. Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as inhibitors of platelet aggregation. 1. Synthesis and pharmacological evaluation.
Campillo N; García C; Goya P; Páez JA; Carrasco E; Grau M
J Med Chem; 1999 May; 42(10):1698-704. PubMed ID: 10346922
[TBL] [Abstract][Full Text] [Related]
3. 2-Nitrosoimino-3,6-dihydro-2H-1,3,4-thiadiazines with antiplatelet and antithrombotic properties.
Rehse K; Brümmer U; Unsöld E
Pharmazie; 1998 Dec; 53(12):820-4. PubMed ID: 9879566
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 2,3-disubstituted 1,4-naphthoquinones as antiplatelet agents.
Lien JC; Wu CR; Hour MJ; Huang LJ; Huang TF; Kuo SC
Arch Pharm (Weinheim); 2008 Oct; 341(10):639-44. PubMed ID: 18720342
[TBL] [Abstract][Full Text] [Related]
6. Pyridazines part 41: synthesis, antiplatelet activity and SAR of 2,4,6-substituted 5-(3-oxo-3-phenylprop-1-en-1-yl)- or 5-(3-phenylprop-2-enoyl)pyridazin-3(2H)-ones.
Crespo A; Meyers C; Coelho A; Yáñez M; Fraiz N; Sotelo E; Maes BU; Laguna R; Cano E; Lemière GL; Raviña E
Bioorg Med Chem Lett; 2006 Feb; 16(4):1080-3. PubMed ID: 16290144
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacological evaluation of a second generation of pyridothiadiazine 1,1-dioxides acting as AMPA potentiators.
Francotte P; de Tullio P; Podona T; Diouf O; Fraikin P; Lestage P; Danober L; Thomas JY; Caignard DH; Pirotte B
Bioorg Med Chem; 2008 Dec; 16(23):9948-56. PubMed ID: 18980844
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
Wang WY; Hsieh PW; Wu YC; Wu CC
Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and structure-activity relationships of a novel series of 5-alkylidenepyridazin-3(2H)-ones with a non-cAMP-based antiplatelet activity.
Coelho A; Raviña E; Fraiz N; Yáñez M; Laguna R; Cano E; Sotelo E
J Med Chem; 2007 Dec; 50(26):6476-84. PubMed ID: 18031002
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiplatelet activity of ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) derivatives.
Chen HS; Kuo SC; Teng CM; Lee FY; Wang JP; Lee YC; Kuo CW; Huang CC; Wu CC; Huang LJ
Bioorg Med Chem; 2008 Feb; 16(3):1262-78. PubMed ID: 17988878
[TBL] [Abstract][Full Text] [Related]
12. [The antiaggregant action of 2-morpholino-5-(thienyl-2)-6-H-1,3,4-thiadiazine in in vitro and ex vivo experiments].
Logvinova IuS; Makarov VA; Chupakhin ON; Sidorova LP; Perova NM; Rusinov VL
Eksp Klin Farmakol; 2013; 76(2):13-6. PubMed ID: 23631277
[TBL] [Abstract][Full Text] [Related]
13. Ligustrazine derivatives. Part 3: Design, synthesis and evaluation of novel acylpiperazinyl derivatives as potential cerebrocardiac vascular agents.
Cheng XC; Liu XY; Xu WF; Guo XL; Zhang N; Song YN
Bioorg Med Chem; 2009 Apr; 17(8):3018-24. PubMed ID: 19329327
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-HIV evaluation of novel 1,3-disubstituted thieno[3,2-c][1,2,6]thiadiazin-4(3H)-one 2,2-dioxides(TTDDs).
Lin Y; Liu X; Yan R; Li J; Pannecouque C; Witvrouw M; De Clercq E
Bioorg Med Chem; 2008 Jan; 16(1):157-63. PubMed ID: 17964796
[TBL] [Abstract][Full Text] [Related]
15. [Antiaggregant properties of new 1,3,4-thiadiazine derivatives].
Vasil'eva TM; Makarov VA; Chupakhin ON; Sidorova LP; Perov NM; Rusinov VL
Eksp Klin Farmakol; 2009; 72(5):27-30. PubMed ID: 19928572
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-platelet evaluation of 2-benzoylaminobenzoate analogs.
Hsieh PW; Chiang SZ; Wu CC; Lo YC; Shih YT; Wu YC
Bioorg Med Chem; 2008 May; 16(10):5803-14. PubMed ID: 18407506
[TBL] [Abstract][Full Text] [Related]
17. [PAF-antagonists with phospholipid structure. 3. Phospholipids with heterocyclane head groups and variations of the phosphorus-nitrogen distance; synthesis, characterization and structure-activity relationship].
Kertscher HP; Ostermann G
Pharmazie; 1991 Nov; 46(11):772-4. PubMed ID: 1811226
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, antiplatelet and in silico evaluations of novel N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides.
Jordão AK; Ferreira VF; Lima ES; de Souza MC; Carlos EC; Castro HC; Geraldo RB; Rodrigues CR; Almeida MC; Cunha AC
Bioorg Med Chem; 2009 May; 17(10):3713-9. PubMed ID: 19380229
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of N1-substituted benzamidines. Effects on blood coagulation, platelet aggregation and antiarrhythmic activity.
Ferroni R; Simoni D; Manfredini S; Guarneri M; Orlandini P; Barbieri M; Franzè GP; Mugelli A
Arzneimittelforschung; 1995 Jun; 45(6):665-9. PubMed ID: 7646567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
